␤-L-Dioxolane-cytidine (L-OddC, BCH-4556, Troxacitabine) is a novel unnatural stereochemical nucleoside analog that is under phase II clinical study for cancer treatment. This nucleoside analog could be phosphorylated and subsequently incorporated into the 3 terminus of DNA. The cytotoxicity of L-OddC was correlated with the amount of L-OddCMP in DNA, which depends on the incorporation by DNA polymerases and the removal by exonucleases. Here we reported the purification and identification of the major enzyme that could preferentially remove L-OddCMP compared with dCMP from the 3 termini of DNA in human cells. Surprisingly, this enzyme was found to be apurinic/apyrimidinic endonuclease (APE1) (1), a well characterized DNA base excision repair protein. APE1 preferred to remove L-over D-configuration nucleosides from 3 termini of DNA. The efficiency of removal of these deoxycytidine analogs were as follows:
Deoxyribonucleoside analogs are among the most effective agents for the treatment of cancer and viral diseases. Most of these compounds exert their function by inhibiting cellular or viral DNA synthesis. Since the naturally occurring nucleosides are in the ␤-D-configuration, most of the nucleoside analogs were designed in that configuration. The discovery of ␤-L-2Ј,3Ј-dideoxy-3Ј-thiocytidine (L-SddC, 3TC), 1 a stereochemically unnatural L-nucleoside analog ( Fig. 1) inhibitor of HIV and hepatitis B virus replication (2-6), defined a new category for the design of nucleoside analogs. Among these, ␤-L-dioxolane-cytidine (L-OddC) ( Fig. 1) is the first to show potential anticancer activity (2, 3) , and clinical evaluation demonstrates its effectiveness against both leukemia and solid tumors (4 -7). For activation, most nucleoside analogs require conversion to the triphosphate metabolite by several cellular enzymes. Our previous studies have shown that L-OddC can be phosphorylated by deoxycytidine kinase to its monophosphate metabolite, which is further phosphorylated by cellular kinases to its di-and triphosphate metabolites (2, 3) . The latter form of L-OddC can be incorporated into DNA by DNA polymerases ␣, ␤, ␦, ␥, and ⑀ in vitro (8) . Since L-OddC lacks a hydroxyl group at the 3Ј-position, it causes premature termination of DNA replication once incorporated and eventually leads to cell death. This chain termination is probably the major mechanism of action of L-OddC. We have also shown previously that the cytotoxicity of this drug is directly related to the steady-state level of L-OddC in DNA (2).
The steady-state level of L-OddC in DNA is not only dependent on incorporation by DNA polymerases but also on the excision by DNA repair enzymes. We have previously observed that incorporated L-OddCMP could be excised from the DNA in cells (2) . However, of the several DNA exonucleases that have been studied to date, all showed preference for D-over L-configuration nucleoside analogs at the 3Ј termini of DNA (8 -15) , making them unlikely candidates as the enzyme responsible for the removal of L-OddC from DNA. In this study, we used the nuclei from leukemic cells of patients to identify the major enzymatic activity that removes L-OddCMP from DNA as human apurinic/apyrimidinic (AP) DNA endonuclease (APE1), also known as HAP-1 or Ref-1 (1, 16 -18) .
APE1 is a 35-kDa monomeric protein that possesses multiple activities related to DNA metabolism. APE1 belongs to the class II AP endonucleases and is the major cellular enzyme responsible for repairing AP sites in DNA (1, 16, 19 -21) . The DNA repair activities reside in the C-terminal region (22) . APE1 initiates the DNA base excision repair by cleaving the DNA immediately adjacent to the 5Ј of an AP site to produce a hydroxyl group at the 3Ј terminus of an unmodified nucleotide upstream of the nick and a 5Ј-deoxyribose phosphate moiety downstream. The product of APE1 is further processed by DNA polymerase ␤ to release 5Ј-deoxyribose phosphate with its intrinsic lyase activity and to fill up the one-nucleotide gap with its DNA polymerase activity (23). The nicked DNA is then sealed by DNA ligase I or DNA ligase III/XRCC1 to complete this repair process. In addition to the AP endonuclease activity, APE1 also possesses a 3Ј-5Ј DNA exonuclease activity, a 3Ј-phosphodiesterase activity, a 3Ј-phosphatase activity, and a * This work was supported by NCI, National Institutes of Health, Grants CA 63477 and AI 39204. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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In addition to its DNA repair activities, APE1 plays a role in regulating gene expression. The N-terminal domain of this protein has a redox regulatory function (17, 27, 28) . Through this domain, APE1 mediates the reductive activation of oxidized proteins such as c-Jun and c-Fos as well as Myb, nuclear factor B, and members of CREB family to facilitate their specific DNA binding ability (18, 29) . A mouse knock-out of APE1 resulted in an embryonic lethal phenotype (30, 31) , further emphasizing the importance of this gene for normal cellular functioning.
The 3Ј-5Ј DNA exonuclease activity was reported to be between 3 and 4 orders of magnitude less efficient than the AP endonuclease activity (32) and hence was not considered biologically significant. In view of our current study, this exonuclease activity could be much more important than that previously suggested. Besides L-OddC terminated oligonucleotide, we also examined the effectiveness of APE1 exonuclease activity against the antiviral deoxyoligonucleotides analogs L-SddC, L-Fd4C (33, 34) , ddC (35, 36) , L-ddC (37) , and the anticancer analogs such as dFdC (38 -41) and araC (42, 43) (Fig. 1) . The exonuclease activity of APE1 showed a preference for L-configuration nucleoside analogs over the natural D-configuration analogs. Moreover, the product of APE1 exonuclease could also be extended by polymerases, which suggested that APE1 could be the key enzyme involved in removing L-configuration nucleoside analogs from the 3Ј termini of DNA. The potential importance of this APE1 exonuclease activity in determining the toxicity of deoxyribonucleoside analogs is discussed. P]dATP and further extended with OddCMP by E. coli DNA polymerase Klenow fragment (exonuclease-free) enzyme in 50 mM Tris-HCl, pH 7.5, 1 mM dTT, and 50 g/ml bovine serum albumin at 37°C for 5 min. To monitor other exonucleases with different substrate preferences, double-stranded oligonucleotide B (Sequence 2) was labeled with [␣Ϫ 32 P]dCTP using E. coli DNA polymerase Klenow fragment in 50 mM Tris-HCl, pH 7.5, 1 mM dTT, and 50 g/ml bovine serum albumin at 37°C for 5 min. The products were purified using G-50 spin columns (Roche Molecular Biochemicals) to remove radioactive nucleotides. The purity of the products was examined by a 12.5% urea/ polyacrylamide gel electrophoresis in 1ϫ TBE buffer (89 mM Tris, 89 mM boric acid, 2.5 mM EDTA, pH 8.3).
Since there was no 5Ј-phosphatase activity in the final enzyme purification, to facilitate the characterization of APE1 exonuclease activity and substrate specificity, both oligonucleotides C and D were 5Ј-endlabeled with [␥Ϫ 32 P]ATP using T4 polynucleotide kinase. Following the kinase reaction, 50 M L-OddCTP and 1 unit of deoxynucleotidyl terminal transferase (Amersham Pharmacia Biotech) was added to oligonucleotide C (Sequence 3) and the mixture was incubated at 37°C for 30 min. Oligonucleotides C and D (Sequence 4) were then rendered doublestranded by the addition of the 33-nucleotide complementary strand.
3ЈϪ CAC CGC GCC TCT GAA TCT CTG TAA ACC GCG CCCϪ5Ј
SEQUENCE 4
The AP endonuclease activity was assayed with a synthetic tetrahydrofuran (F) containing oligonucleotide E as listed in Sequence 5. 
APE1 Preferentially Removes L-OddCMP from 3Ј Termini of DNA
3Ј-or 5Ј-labeled oligonucleotides and 20 mM Tris-HCl, pH 7.5, 2 mM MgCl 2 , 0.5 mM EDTA, 30 mM KCl, and 0.1 mg/ml bovine serum albumin. 1 l of different dilutions of enzyme was added to the reaction mixtures for 30 min at 37°C. The reaction was stopped by adding 4 l of loading solution (90% formamide, 1 mM EDTA, 0.1% xylene cyanol, and 0.1% bromphenol blue) and heating at 80°C for 3 min. Samples (3 l) were loaded onto a 12.5% polyacrylamide gel containing 8 M urea, which was electrophoresed in 1ϫ TBE buffer. The gel was then dried under vacuum and subjected to autoradiography and a phosphor-imaging screen (Bio-Rad).
Purification of 3Ј-5Ј DNA Exonuclease Activity with Specificity against L-(Ϫ)-OddCMP-All purification procedures were performed at 4°C unless otherwise indicated. The buffers used in purification were as follows: buffer A, 20 mM Tris-HCl, pH 7.4, 300 mM KCl, 2 mM benzamidine, 1 mM PMSF, 1 mM DTT, 0.5 g/ml leupeptin, 0.5 g/ml pepstatin A, 20% glycerol; buffer B, 20 mM Tris-HCl, pH 7.4, 50 mM KCl, 2 mM benzamidine, 1 mM PMSF, 1 mM DTT, 0.5 g/ml leupeptin, 0.5 g/ml pepstatin A, 20% glycerol; buffer C, 20 mM Tris-HCl, pH 7.4, 600 mM KCl, 2 mM benzamidine, 1 mM PMSF, 1 mM DTT, 0.5 g/ml leupeptin, 0.5 g/ml pepstatin A, 20% glycerol; buffer D, 20 mM Tris-HCl, pH 7.4, 1 M KCl, 2 mM benzamidine, 1 mM PMSF, 1 mM DTT, 0.5 g/ml leupeptin, 0.5 g/ml pepstatin A, 20% glycerol; buffer E, 20 mM TrisHCl, pH 7.4, 2 mM benzamidine, 1 mM PMSF, 1 mM DTT, 0.5 g/ml leupeptin, 0.5 g/ml pepstatin A, 20% glycerol.
Crude Nuclei Extract-The 3Ј-5Ј DNA exonuclease that removed L-OddCMP was purified from the nuclei of acute lymphocytic leukemia cells removed by leukophoresis from patients in blast crisis. The procedures for purifying cellular nuclei from leukemic cells were described (11) . Frozen nuclei pellets (50 g) were thawed in 150 ml of buffer A. The nuclei debris was removed by centrifugation at 27,500 rpm for 60 min, and the supernatant was collected (fraction I) for further purification.
DE52 Anion Exchange-A DE52 anion exchange column was used to remove nucleic acids from the supernatant of the crude extract. A 50-ml DE52 column was packed and equilibrated with buffer A. Fraction I was loaded onto the column at a flow rate of 1.5 ml/min, the column was washed with 3 bed volumes of buffer A. Both the flow-through and wash fractions were collected and pooled (fraction II).
P11 Cation Exchange-Fraction II was dialyzed against buffer B until it had the same conductivity as buffer B before it was loaded onto a 50-ml P11 column preequilibrated with buffer B. The column was washed with 3 column volumes of buffer B followed by a 500-ml linear gradient of buffer B to buffer C at a flow rate of 1 ml/min. Fractions were collected and analyzed for exonuclease activity. The active ones were pooled (fraction III).
DE52 Anion Exchange-Fraction III was dialyzed against buffer B and loaded onto a buffer B-preequilibrated DE 52 column. The column was washed with 3 column volumes of buffer B. The proteins were eluted with a 300-ml linear gradient of buffer B to buffer C at a flow rate of 1 ml/min. Fractions were collected and assayed for exonuclease activity. The active fractions were pooled and dialyzed against buffer B (fraction IV).
Single-stranded DNA Cellulose Column-A 15-ml single-stranded DNA cellulose column was packed and preequilibrated with buffer B. Fraction IV was loaded onto the column and washed with 3 column volumes of buffer B. The column was eluted with a 150-ml linear gradient of buffer B to buffer C at a flow rate of 1 ml/min. Fractions were collected, analyzed, pooled, and dialyzed against buffer D (fraction V).
Phenyl-Sepharose Column-Fraction V was loaded onto a 2-ml buffer D-preequilibrated phenyl-Sepharose column. The column was washed with 3 column volumes of buffer D before the application of a 25-ml linear gradient of buffer D to buffer E at a flow rate of 0.5 ml/min. The flow-through (fraction VI) and the active fractions eluted from the column (fraction VII) were collected, pooled, and dialyzed against buffer B.
Concentration on P11 Column-Fractions VI and VII were loaded onto two separate 1-ml P11 columns and eluted with a 10-ml linear gradient of buffer B to buffer C. Active fractions were collected and pooled (fractions VIII and IX, respectively).
SDS-PAGE-Fractions VIII and IX were analyzed by SDS-polyacrylamide gel. After electrophoresis, proteins were visualized by Coomassie Blue staining.
Activity Gel Electrophoresis-The 3Ј-5Ј DNA exonuclease activity was detected in situ after SDS-PAGE by activity gel electrophoresis, following the method of Longley and Mosbaugh (45) with slight modifications. A 10% SDS-polyacrylamide gel was prepared with the addition of 0.1 mM EDTA and 1 nM f1-K12 single-stranded DNA (Sequence 6, bottom), which was annealed to an [␣Ϫ 32 P]dATP-labeled oligonucleotide with L-OddCMP at the 3Ј terminus (Sequence 6, top) as shown.
5ЈϪCCA GGG TTT TCC CAG TCA CG
32P A Odd CϪ3Ј
3ЈϪGGT CCC AAA AGG GTC AGT GC T GϪ5Ј
SEQUENCE 6
Samples (20 l) from fractions VIII and IX were loaded on the gel for electrophoresis at 4°C. After electrophoresis, SDS was extracted from the gel at room temperature by two 30-min incubations with 20 mM Tris-HCl, pH 7.5, 5 mM 2-mercaptoethanol, and 25% (v/v) isopropyl alcohol. To renature the proteins, the gel was then shaken gently at 4°C overnight in 20 mM Tris-HCl, pH 7.5, 5 mM 2-mercaptoethanol, 500 g/ml bovine serum albumin, and 20% glycerol to renature the proteins. The exonuclease activity was renatured by shaking the gel for 3 h at 37°C in renaturation buffer supplemented with 2 mM MgCl 2 . The gel was subsequently dried, and the exonuclease activity was visualized by autoradiography.
Matrix-assisted Laser Desorption Ionization (MALDI) Protein Analysis-The ϳ35-kDa polypeptide on 10% SDS-polyacrylamide gel, which correlated with exonuclease activity from fraction IX in the activity gel analysis, was excised and sent for MALDI protein analysis at the HHMI Biopolymer/Keck Foundation Biotechnology Resource Laboratory (Yale University).
Western Blotting with APE1 Monoclonal Antibody-To further confirm the result of MALDI protein analysis, we performed a Western blot experiment with a monoclonal APE1 antibody (Novus Biologicals, Inc., Littleton, CO). Sample (20 l) from fraction IX was loaded on a 10% SDS-polyacrylamide gel and electrophoresed. The proteins were electrotransferred to a nitrocellulose membrane. The membrane was blocked with 5% milk in PBS supplemented with 0.002% Tween 20 before the addition of monoclonal APE1 antibody. The membrane was later developed using the ECL system (Amersham Pharmacia Biotech) and visualized by exposure to an Eastman Kodak Co. MR film.
Exonuclease Activity of APE1 toward Different Analogs at the 3Ј DNA Terminus-DNA substrates with different deoxyribonucleoside analogs at the 3Ј terminus were made to assess the APE1 exonuclease activity. The different deoxyribonucleoside analogs were incorporated into 32 P-5Ј-end-labeled oligonucleotide C by incubating 20 M of the nucleoside 5Ј-triphosphate analogs and 1 unit of HIV reverse transcriptase (HIV RT) at 37°C for 30 min. The desired oligonucleotide products were purified by electrophoresis on a 20% urea/polyacrylamide gel followed by excising the bands and shaking them gently in 10 mM Tris-HCl, pH 7.5, buffer supplemented with 1 mM EDTA overnight at room temperature to extract the oligonucleotides. These single-stranded oligonucleotides were then annealed to a 33-mer template to form partial doublestranded DNA substrates. These DNA substrates were incubated with same amount of APE1 under the standard exonuclease assay condition, and the result was analyzed on a 12.5% urea/polyacrylamide gel. The gel was subsequently dried followed by autoradiography.
Primer Extension Reaction-To demonstrate that the DNA product of APE1 was extendable by DNA polymerase after removing L-OddCMP, a primer extension reaction was performed using HIV RT. After a 30-min incubation of APE1 with L-OddC terminated DNA in the exonuclease assay condition described earlier, 0.5 units of HIV RT and 30 M dNTPs were added to the reaction mixture to a final volume of 15 l for another 5-min incubation at 37°C. The reaction was stopped by adding 6 l of gel loading solution and heating at 80°C for 3 min before analysis on a 12.5% urea/polyacrylamide gel.
RESULTS

Purification of the Exonuclease That Removed L-(Ϫ)-Odd-CMP from 3Ј
Termini of DNA-The presence of exonuclease activity that removed L-OddCMP was detected in nucleic acidfree crude extract (fraction II). Two L-OddCMP exonuclease activity peaks were observed in the fractions from the P11 column (Fig. 2a) . The first activity peak was eluted between 250 and 290 mM KCl, and the second activity peak (fraction III) was eluted between 400 and 500 mM KCl. Meanwhile, there was only one broad activity without a distinct peak when deoxycytidine-terminated oligonucleotide B was used as substrate (Fig. 2b) . The latter eluted from the column between 250 and 570 mM KCl. The lower bands in Fig. 2a are the released [␣-32 P]dAMP from oligonucleotide A, an indication of the exonuclease action. The dNMPs were sequentially excised after the removal of L-OddCMP by this exonuclease. The 20-mer oligonucleotide product after the removal of L-OddCMP was not always observed, perhaps due to the excess amount of enzyme. However, the distribution of activities in the eluted fractions from column chromatography were different when oligonucleotide A or B was employed, as represented by the intensity of released [␣- 32 P]dAMP at the bottom of the gel. This result suggested that the exonucleases in different fractions had different substrate specificity. Since our purpose was to purify the major exonuclease, which removed L-OddCMP, fraction III was chosen for further purification.
Fraction III was further purified using a DE52 anion exchange column. As shown in Fig. 3a , most of the observed exonuclease activity was not retained on the column (fraction IV) when either L-OddCMP-or dCMP-terminated oligonucleotide DNAs were used as substrates. An insignificant exonuclease activity was found to be bound to the column and had a preference for natural DNA substrate (oligonucleotide B) instead of L-OddCMP (oligonucleotide A).
Fraction IV was further purified using a single-stranded DNA column. The exonuclease eluted from the column between the concentrations of 220 and 350 mM KCl (fraction V) (Fig. 3b) . This was the only exonuclease activity peak detected when either oligonucleotide A or B was used.
Fraction V was further purified using a hydrophobic phenylSepharose column. A fraction of the active protein was not retained on the column (fraction VI). The majority of the activity, however, eluted from the column between 540 and 300 mM KCl (fraction VII) (Fig. 3c) . This exonuclease had activity against both L-OddCMP and dCMP. Fractions VI and VII were each loaded onto a 1 ml P11 column for concentration, and both exonuclease activities eluted from P11 columns at 400 mM KCl (fraction VIII and IX, respectively).
At this stage of purification, a single major polypeptide of approximately 35 kDa and several minor contaminants were observed in fraction IX by Coomassie Blue-stained SDS-PAGE analysis (Fig. 4, lane 1) . In fraction VIII, no major protein bands were discernible (data not shown). The exonuclease activities from fractions VIII and IX were stable at Ϫ20°C when stored in 20 mM Tris-HCl, 300 mM KCl, 1 mM EDTA, 0.1 mM dTT, and 20% glycerol. The enzyme specific activity of fraction IX was determined to be at least 3000 units/mg; the unit of enzyme was defined as removal of 10 pmol of L-OddCMP at the 3Ј termini of DNA at 37°C for 30 min under our assay condition.
In Situ Activity Gel-To identify the DNA exonuclease that removes L-OddC from the 3Ј terminus of DNA, an in situ activity gel technique (45) was used. This analysis confirmed that the 3Ј-5Ј DNA exonuclease was associated with the major of 35-kDa polypeptide in fraction IX (Fig. 4, lane 2) . The polypeptide was recovered from the gel, and a partial amino acid sequence was determined using MALDI. The sequence matched that of APE1, the major base excision repair enzyme. To further confirm the identity of our purified protein, a commercial monoclonal antibody to APE1 was used in Western blot analysis. The antibody identified the same 35-kDa major polypeptide in fraction IX (Fig. 4, lane 3) .
Since one of the major cellular functions of APE1 is believed to be repair of abasic sites in DNA, we tested the activity of our partially purified 35-kDa protein on a double-stranded oligonucleotide containing the AP site analog tetrahydrofuran (F) (oligonucleotide E). Reciprocally, purified recombinant APE1 was incubated with L-OddC-terminated oligonucleotide C to 
FIG. 3.
Exonuclease activity profile from DE52, singlestranded DNA, and phenyl-Sepharose columns. The exonuclease activity was further purified sequentially using a DE52 anion exchange column (a), a single-stranded DNA cellulose column (b), and a phenylSepharose column (c). As described under "Experimental Procedures," a 50 -600 mM KCl linear gradient was applied to both DE 52 and singlestranded DNA columns, and a 1.0 -0 M KCl linear gradient was used for the phenyl-Sepharose column to elute proteins. The exonuclease activity was assayed with either oligonucleotide A or B (data not shown) as described previously.
examine its 3Ј-5Ј exonuclease activity. As shown in Fig. 5 , the partially purified APE1 was able to cleave the furan containing DNA, and the recombinant APE1 possessed 3Ј-5Ј exonuclease activity to remove L-OddC from the 3Ј terminus of DNA.
A triplet polypeptide band with an approximate molecular mass of 44 kDa was also observed in addition to APE1 on Coomassie Blue-stained SDS-polyacrylamide gel from our final preparation (fraction IX). The triplet was also analyzed by MALDI and appeared to be derived from one protein, p38 -2G4, a cell cycle-modulated nuclear protein (46) . A previous report showed that the murine homologous p38 -2G4 co-purified with AP endonuclease (47) from mouse sarcoma cells. However, the recombinant p38 -2G4 had no major impact on the AP endonuclease enzyme activity (47) . Throughout our studies, all of the characteristics of the partially purified APE1 and the recombinant APE1 were very similar (data not shown).
Reaction Parameters of the 3Ј-5Ј DNA Exonuclease Activity of APE1-No exonuclease activity was detected in 20 mM TrisHCl, pH 7.5, buffer supplemented with 30 mM KCl and 1.0 mM EDTA. This 3Ј-5Ј DNA exonuclease activity of APE1 can be restored by adding 2.5 mM divalent cation Mg 2ϩ or Mn 2ϩ (data not shown). However, Ca 2ϩ or Zn 2ϩ could not restore the activity. The optimal salt concentration for APE1 exonuclease activity was 30 mM KCl, while 50% of the enzyme activity was inhibited between 60 and 90 mM KCl (data not shown).
Since polyamines were shown to have impact on some DNAassociated enzyme activities (48), the effect of polyamine on this exonuclease activity of APE1 was also addressed. Spermine and spermidine showed 50% inhibition at concentrations of 0.1 and 0.2 mM, respectively, but 2 mM putrescine was required to show 50% inhibition (data not shown).
Substrate Specificity of APE1 Exonuclease Action-Previous reports indicated that the 3Ј-5Ј DNA exonuclease activity of APE1 is 3-4 orders of magnitude less efficient than the AP endonuclease activity. In our study, the exonuclease activity of APE1 was the major enzyme activity to remove L-OddC from the 3Ј termini of DNA. Since L-OddC is an unnatural L-configuration nucleoside analog, we compared the substrate preference between L-OddCMP and dCMP terminated DNA. As shown in Fig. 6a , L-OddCMP-terminated DNA was a better substrate than dCMP-terminated DNA. Furthermore, to elucidate whether DNAs with L-deoxyribonucleoside analogs at the 3Ј termini were preferable substrates for APE1 exonuclease activity over DNA with a D-configuration deoxyribonucleoside, three different D-configuration deoxyribonucleoside analogs (dFdC, araC, and ddC) and four L-configuration analogs: L-ddC, L-OddC, L-Fd4C, and L-SddC were examined as substrates. The different analogs at the 3Ј terminus caused slight differences in mobility on 12.5% urea/polyacrylamide gel otherwise identical oligonucleotide (Fig. 6a) . The relative removal efficiency of different analogs from the 3Ј termini is reported in Table I (data normalized to that of L-OddC, which was considered 100%). The 3Ј-5Ј DNA exonuclease activity of APE1 exhibited a substrate preference for the L-configuration analogs at the 3Ј termini of DNA over the D-configuration analogs. The 5-fold removal efficiency of L-ddC over the ddC is a good example that the L-configuration analog is a better substrate for the exonuclease activity. Among these four L-configuration analogs, LOddC was the best substrate for this exonuclease. L-Fd4C, a nucleoside analog with the introduction of a fluoride on the 5-position of cytosine and a double bond between the 2Ј-and 3Ј-carbon of the L-deoxyribose moiety, was also a good substrate of this exonuclease. Interestingly, replacing the 2Ј-oxygen of sugar moiety of L-OddC with a sulfur (L-SddC) reduced the removal efficiency 2-fold.
In comparison with the double-stranded DNA substrates, single-stranded DNAs with different deoxyribonucleoside analogs at the 3Ј termini were not substrates for the exonuclease activity of APE1 under the same reaction conditions (data not shown).
The product of APE1 after removal of L-OddCMP from the 3Ј termini was also examined to see if it could be extended by DNA polymerase-HIV RT in this study. As shown in Fig. 6b , in the presence of dNTPs, HIV RT could not extend L-OddCMPterminated DNA. However, after the removal of L-OddCMP by   FIG. 4 . Identification of the major DNA exonuclease for the removal of L-OddC from the 3 terminus of DNA. Lane 1, aliquot (20 l) from fraction IX was subjected to a SDS-PAGE analysis followed by Coomassie Blue staining. Lane 2, L-OddC-containing DNA substrate was embedded in a 10% SDS-polyacrylamide gel. An aliquot (20 l) from fraction IX was subjected to electrophoresis. The enzymatic activity that removed L-OddC was visualized by autoradiography after the renaturation treatment, as described under "Experimental Procedures." Lane 3, same procedures as in lane 1, but the polypeptides were electrotransferred to a nitrocellulose membrane after SDS-PAGE. The membrane was subsequently probed with monoclonal APE1 antibody and developed using the ECL system. The result was visualized by exposing to a Kodak MR film. APE1, HIV RT was able to extend the product, indicating the presence of a 3Ј-hydroxyl group.
DISCUSSION
One of the major mechanisms of action of deoxyribonucleoside analogs is the incorporation into DNA by DNA polymerases followed by cessation of cellular or viral DNA synthesis. However, the steady-state level of deoxyribonucleoside analogs in DNA depends on several factors, such as the enzymes involved in the process of metabolizing these deoxyribonucleoside analogs to deoxyribonucleotides, the DNA polymerases that incorporate analogs into DNA, and DNA repair enzymes that can remove these analogs from DNA. The incorporation of the novel anticancer drug L-OddCMP into DNA has been shown to terminate DNA elongation (3) . However, DNA with L-OddC at the 3Ј termini may be subject to actions of DNA exonucleases. Indeed, a previous study indicated that the extent of L-OddC in DNA was correlated with the cytotoxicity of L-OddC and that L-OddCMP could be removed from DNA in cultured cells (2) .
Several non-DNA polymerase-associated exonucleases with the ability to remove nucleoside analogs from the 3Ј terminus of DNA have been identified (8 -15) . The physiological role of these exonucleases is presumably the maintenance of DNA integrity; however, none of those studied showed preference for the removal of L-configuration deoxyribonucleoside analogs from the 3Ј end of DNA (8 -15) . Here we report the purification and identification of APE1 as the major DNA 3Ј-5Ј exonuclease from the nuclei of human leukemic blast cells that can remove L-OddCMP from DNA preferentially.
APE1 is a multiple function enzyme, which in addition to its DNA endonuclease and 3Ј-5Ј DNA exonuclease activity, also possesses 3Ј-phosphatase, 3Ј-phosphodiesterase, and RNaseH activity. The 3Ј-5Ј DNA exonuclease activity was reported to be 3-4 orders of magnitude less active than the endonuclease activity. Demple et al. (32) reported that the exonuclease activity of APE1 is sensitive to the reaction buffer condition and the nature of duplex DNA substrates. Our results are consistent with the fact that DNA with dCMP at the 3Ј termini is a poor substrate for APE1 exonuclease but DNA with L-OddCMP at the 3Ј termini was a good substrate.
The proposed mechanism for the endonuclease activity of APE1 involves a divalent cation stabilization of a transitional state leading to hydrolysis by facilitating the leaving of the phosphate group. A similar mechanism could be involved in the exonuclease activity, since the latter also requires divalent cations. The observation that requirement of Mg 2ϩ or Mn 2ϩ could not be substituted by Ca 2ϩ or Zn 2ϩ might be due to a less than ideal coordination between these metal ions and critical amino acid residues in the catalytic site.
Polyamines also influenced APE1 exonuclease activity. Spermine, spermidine, and putrescine inhibited the exonuclease activity at physiological concentrations. Since polyamines are highly positive molecules, they could alter DNA structure and stabilize the staggering base pairing between L-OddC and deoxyguanosine and therefore affect the cleavage by APE1 exonuclease activity.
The substrate preference for L-OddC over dCyd is likely to be caused by the unnatural configuration of L-OddC. According to computer modeling, the unnatural configuration of L-OddC does not affect the base stacking stability and hydrogen bonding in DNA. The substrate preference for L-versus D-configuration analogs of APE1 exonuclease was clearly shown, when DNA substrates with D-or L-ddC at the 3Ј termini were used. This APE1 exonuclease showed a 5-fold higher efficiency in removing L-ddC over D-ddC, which is very different from the exonuclease activities reported to date. The hypothesis that L-configuration nucleoside analogs are better substrates for the exonuclease activity of APE1 was further supported when L-Fd4C-and L-SddC-terminated substrates were tested. In general, L-configuration analogs are better substrates than the D-configuration substrates for the exonuclease activity of APE1. This is very different from the exonuclease activity reported by others before. For example, TREX-1 was shown to remove araCMP and dNMP from the 3Ј terminus of DNA (14) , and cytosolic and p53 associated exonucleases have preferences for removal of D-configuration nucleoside analogs over L-configuration analogs from 3Ј termini of DNA (9, 10). Crystal FIG. 6 . APE1 exonuclease activity toward partial doublestranded DNA with different deoxycytidine analogs at the 3 terminus. a, the DNA substrates with different deoxycytidine analogs at the 3Ј termini were examined for removal efficiencies of APE1. b, The purified APE1 was incubated with oligonucleotide C for 30 min at 37°C before the addition of HIV RT and dNTPs.
TABLE I
The efficiency of removing various analogs from the 3Ј termini of DNA by APE1 exonuclease DNA oligonucleotides with various analogs at the 3Ј terminus were used as substrates for APE1 exonuclease activity. The reaction conditions were as described under "Experimental Procedures." The removal efficiency was calculated by dividing the product radioactivity by the total radioactivity of substrate and product. The efficiencies of removal of different analogs were adjusted using the efficiency of L-OddCMP removal as a 100% standard. structure analysis revealed that binding of APE1 to AP DNA resulted in a flipped-out AP site and a racemized ␤-anomer AP site (49) . Since the endonuclease and exonuclease activities of APE1 are believed to share the same catalytic site (20) , the unnatural structure of L-OddCMP may mimic the structure of the transition state during APE1 endonuclease action on AP sites, explaining why L-OddC and other L-configuration nucleoside analogs are better substrates of APE1 than dCyd at the 3Ј termini of DNA. Although APE1 exonuclease has a preference for L-configuration analogs, the removal efficiency was different among the analogs examined. In the case of L-SddC, the replacement of oxygen with a sulfur on the 3Ј-position of the deoxyribose moiety reduced the efficiency 2-fold when compared with LOddC. The introduction of a double bond between the 2Ј-and 3Ј-position on the deoxyribose moiety in L-Fd4C decreased the efficiency about 20% compared with that of L-OddC. These results suggested that the configuration and structure of the deoxyribose could play an important role in determining the substrate specificity for APE1 exonuclease. Molecular modeling and the kinetics of APE1 exonuclease toward different deoxyribonucleoside analogs at the 3Ј terminus need to be further studied to facilitate understanding of the substrate specificity.
Since the DNA product of the exonuclease activity of APE1 after removal of L-OddC can be extended by DNA polymerases, it is likely that no other enzyme is required during the excision step of the repair process. It is possible that the intracellular activity of APE1 may have an important influence in determining the pharmacological effects of L-OddC and other L-configuration nucleoside analogs but not for the D-configuration nucleoside analogs such as dFdC, araC, or ddC.
Previous reports demonstrated the importance of APE1 during the early embryonic development and growth in mice (30, 31) . The discovery of this novel activity of APE1 suggests that it may be important not only for its AP endonuclease and redox activities but also as an exonuclease. Correlation between APE1 expression level in the cell, the redox state, the phosphorylation status, and the cytotoxicity of deoxyribonucleoside analogs requires further investigation.
